ArticleJournal of ovarian research2014

Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.